Mackay Shields LLC Ultragenyx Pharmaceutical Inc. Transaction History

Mackay Shields LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$92.19 - $115.71 $1.91 Million - $2.4 Million	-20,735 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $1.37 Million - $2.15 Million	-12,836 Reduced 38.24%	20,735 $2.36 Million
Q4 2020 Feb 16, 2021	SELL	$84.4 - $177.39 $379,800 - $798,254	-4,500 Reduced 11.82%	33,571 $4.65 Million
Q3 2020 Nov 04, 2020	SELL	$72.98 - $90.0 $372,198 - $459,000	-5,100 Reduced 11.81%	38,071 $3.13 Million
Q2 2020 Jul 31, 2020	BUY	$46.91 - $78.22 $150,112 - $250,304	3,200 Added 8.01%	43,171 $3.38 Million
Q1 2020 May 08, 2020	SELL	$33.8 - $62.9 $216,319 - $402,560	-6,400 Reduced 13.8%	39,971 $1.78 Million
Q4 2019 Feb 11, 2020	SELL	$36.08 - $45.83 $21,648 - $27,498	-600 Reduced 1.28%	46,371 $1.98 Million
Q3 2019 Nov 01, 2019	SELL	$42.5 - $63.11 $34,000 - $50,488	-800 Reduced 1.67%	46,971 $2.01 Million
Q2 2019 Aug 13, 2019	BUY	$54.93 - $74.36 $1.69 Million - $2.29 Million	30,836 Added 182.08%	47,771 $3.03 Million
Q1 2019 May 13, 2019	BUY	$39.87 - $69.36 $51,831 - $90,168	1,300 Added 8.31%	16,935 $1.17 Million
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $64,674 - $128,549	-1,663 Reduced 9.61%	15,635 $679,000
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $136,439 - $171,285	1,900 Added 12.34%	17,298 $1.32 Million
Q2 2018 Aug 06, 2018	SELL	$48.54 - $85.31 $14,562 - $25,593	-300 Reduced 1.91%	15,398 $1.18 Million
Q1 2018 May 03, 2018	BUY	$44.33 - $58.52 $695,892 - $918,646	15,698 New	15,698 $800,000

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.04B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.